首页> 外国专利> New derivatives of (1H-Indol-3-Ilmethyl) Dimethylamine with blocking activity of voltage-dependent Ca2 + channels, preferably NO-L, and their application in the treatment of diseases of the nervous system

New derivatives of (1H-Indol-3-Ilmethyl) Dimethylamine with blocking activity of voltage-dependent Ca2 + channels, preferably NO-L, and their application in the treatment of diseases of the nervous system

机译:具有电压依赖性Ca 2 +通道(优选为NO-L)具有阻断活性的(1H-吲哚-3-III甲基)二甲胺新衍生物及其在神经系统疾病治疗中的应用

摘要

New derivatives of (1H-INDOL-3-ILMETIL) Dimethylamine with blocking activity of the voltage-dependent Ca {sup, 2 +} channels, preferably NO-L, and their application in the treatment of diseases of the nervous system. # { IMAGE-01} #The present invention relates to compounds of general formula (I), and their use in the manufacture of medicaments useful for the treatment of diseases of the central and peripheral nervous system, such as neurodegenerative diseases, stroke, epilepsy , migraine, neuropathic pain or, in general, any disease caused by the alteration of the biological functions on which these products act. One of the therapeutic strategies to treat these diseases is the reduction of Ca {sup, 2 +} input through voltage-dependent Ca {sup, 2 +} (CCDV) channels. Thus, the compounds claimed in this invention regulate the homeostasis of Ca {sup, 2 +} in excitable cells, which is altered in these conditions. Among all types of CCDV, the compounds of general formula (I) preferably act by the so-called non-L, so they would lack peripheral side effects of hemodynamic type, where CCDV type L are predominant. The present invention can be framed in the field of the pharmaceutical industry.
机译:(1H-INDOL-3-ILMETIL)二甲胺的新衍生物具有电压依赖性Ca {sup,2 +}通道(优选为NO-L)的阻断活性,并将其应用于神经系统疾病的治疗。 #{IMAGE-01}#本发明涉及通式(I)的化合物,及其在制备用于治疗中枢神经系统和周围神经系统疾病例如神经退行性疾病,中风,癫痫病的药物中的用途,偏头痛,神经性疼痛或通常由这些产品作用的生物学功能改变引起的任何疾病。治疗这些疾病的一种治疗策略是减少通过电压依赖性Ca {sup,2 +}(CCDV)通道输入的Ca {sup,2 +}。因此,本发明要求保护的化合物调节可兴奋细胞中Ca {sup,2 +}的体内稳态,其在这些条件下改变。在所有类型的CCDV中,通式(I)的化合物优选通过所谓的非-L起作用,因此它们将缺乏血流动力学型的外围副作用,其中以CCDV型L为主。本发明可以在制药工业领域中实现。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号